Trevi Therapeutics, Inc. (TRVI) Social Stream



Trevi Therapeutics, Inc. (TRVI): $2.69

0.01 (-0.55%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

TREVI THERAPEUTICS INC (TRVI) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering TREVI THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-13 2 $10 $10 $10 $1.35 640.74%
2021-11-10 2 $10 $8 $9 $1.35 566.67%
2022-01-13 2 $8 $8 $8 $1.35 492.59%
2022-05-12 3 $8 $8 $8 $1.35 492.59%
2022-05-25 4 $10 $8 $8.666 $1.35 541.93%
2022-08-11 4 $10 $8 $9.333 $1.35 591.33%
2022-10-02 4 $12 $8 $10 $1.35 640.74%
2022-11-11 4 $12 $8 $9.333 $1.35 591.33%
2022-11-14 5 $9 $8 $8.333 $1.35 517.26%
2023-03-17 4 $9 $6 $7.75 $1.35 474.07%
2023-11-17 5 $9 $6 $7.4 $1.35 448.15%

The Trend in the Analyst Price Target


Over the past 22 months, TRVI's average price target has gone down $0.6.

TRVI reports an average of 281% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-08 5 9 6 7.75 2.52 207.54%
2023-10-16 5 9 6 7.40 1.88 293.62%
2023-11-02 5 9 6 7.40 1.66 345.78%
2023-11-10 5 9 6 7.40 1.31 464.89%
2023-11-17 5 9 6 7.40 1.39 432.37%

TRVI Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 4 1 0 0 0 5

The Trend in the Broker Recommendations


TRVI's average broker recommendation rating improved by 0.05 over the prior 13 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how TREVI THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1418.65% of that group.
  • In terms of how TREVI THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 131.94% of that group.
  • TREVI THERAPEUTICS INC's number of analysts covering the stock is greater than 170.29% of all US stocks.
  • TRVI has a lower variance in analysts' estimates than -66.97% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TREVI THERAPEUTICS INC are HOTH, TLSA, and RVPH.

Make investment decisions regarding TRVI using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!